Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc exhibits a promising outlook as its innovative Enhanced Delivery Oligonucleotide (EDO) platform has demonstrated superior splicing correction rates, achieving a notable 53.7%—significantly higher than competitors. The ongoing anticipation of multi-dose data from its clinical pipeline is expected to highlight substantial potential for positive risk/benefit profiles, potentially driving further investor interest and stock value. With shares currently trading around $4, there is a considerable market opportunity as favorable clinical outcomes could translate into both improved therapy effectiveness and enhanced market capitalization for the company.

Bears say

PepGen Inc.'s recent updates indicate a $1 decrease in its target price to $8 per share, highlighting challenges in maintaining investor confidence despite the company delivering promising clinical data. The company's market cap appears significantly undervalued compared to competitors, which raises concerns about its future execution and the ability to meet or exceed market expectations. Additionally, potential difficulties in accessing capital markets could hinder the development of its pipeline products, increasing the risk of delays or termination of critical campaigns.

PepGen Inc (PEPG) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 4 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Feb 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.